Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Neuroma, Acoustic/radiotherapy"'
Autor:
Tuleasca, C., Toma-Dasu, I., Duroux, S., Starnoni, D., George, M., Maire, R., Daniel, R.T., Patin, D., Schiappacasse, L., Dasu, A., Faouzi, M., Levivier, M.
Publikováno v:
Neurosurgery, vol. 92, no. 6, pp. 1216-1226
BACKGROUND: Stereotactic radiosurgery has become a common treatment approach for small-to-medium size vestibular schwannomas. OBJECTIVE: To evaluate relationship between time (beam-on and treatment) and risk of hearing decline after stereotactic radi
Autor:
Anne Balossier, Constantin Tuleasca, Christine Delsanti, Lucas Troude, Jean-Marc Thomassin, Pierre-Hugues Roche, Jean Régis
Publikováno v:
Neurosurgery, vol. 92, no. 6, pp. 1130-1141
BACKGROUND: Stereotactic radiosurgery (SRS) is one of the main treatment options in the management of small to medium size vestibular schwannomas (VSs), because of high tumor control rate and low cranial nerves morbidity. Series reporting long-term h
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::30e79283f2b8ea24fa700d1cff243602
https://serval.unil.ch/notice/serval:BIB_C6234B56221B
https://serval.unil.ch/notice/serval:BIB_C6234B56221B
Autor:
Selcuk Peker, Yavuz Samanci, Inan Erdem Ozdemir, Henricus P. M. Kunst, Daniëlle B. P. Eekers, Yasin Temel
Publikováno v:
Neurosurgical Review, 46(1). Springer, Cham
Neurosurgical Review, 46, 2
Neurosurgical Review, 46, 1, pp. 2
Neurosurgical Review, 46, 2
Neurosurgical Review, 46, 1, pp. 2
Background: Anecdotally, cystic vestibular schwannomas (cVSs) are regarded to have unpredictable biologic activity with poorer clinical results and most studies showed a less favorable prognosis following surgery. While stereotactic radiosurgery (SRS
Autor:
Constantin Tuleasca, Mohamed Faouzi, Raphael Maire, Philippe Maeder, Jonathan P.S. Knisely, Marc Levivier
Publikováno v:
Neurosurgical Review
Neurosurgical review, vol. 44, no. 6, pp. 3527-3537
Neurosurgical review, vol. 44, no. 6, pp. 3527-3537
Vestibular schwannomas (VSs) are benign, slow-growing tumors. Management options include observation, surgery, and radiation. In this retrospective trial, we aimed at evaluating whether biologically effective dose (BED) plays a role in tumor volume c